
Flexjak 11mg Tablet ER
Marketer
Abbott Healthcare Private Limited
Salt Composition
Tofacitinib (11mg)
Overview Flexjak 11mg Tablet ER
Artiva 11mg Extended-Release Tablets are indicated for managing moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, and also helps retard the progression of bone and joint deterioration. Artiva 11mg ER may be administered alone or in conjunction with other therapies. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your medical history and other medications. Always adhere to your physician's prescribed regimen; abrupt cessation should only occur under their guidance as it could exacerbate your condition. Commonly reported adverse effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, side effects such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Report any concerns regarding side effects to your doctor. Pre-treatment blood work may be necessary, and initiation of therapy is contraindicated in the presence of any infection. Prior to commencing treatment, discuss your medical history with your physician, including any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or thromboembolic events. Artiva 11mg ER increases susceptibility to infection; avoid contact with individuals exhibiting contagious illnesses (e.g., varicella, rubeola, influenza). This medication is unsuitable for patients under 18 years of age and should not be used during pregnancy or lactation except when deemed medically necessary by your doctor. Regular monitoring by your physician may be required.
Uses of Flexjak 11mg Tablet ER
Managing rheumatoid, psoriatic, and ankylosing spondylitis, plus ulcerative colitis.
Major Benefits of Flexjak 11mg Tablet ER:
Administer Flexjak 11mg Extended-Release Tablets precisely as directed by your physician. Ingest the tablet whole; avoid chewing, crushing, or fracturing. This medication can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Flexjak 11mg Tablet ER:
- Upper respiratory tract infection
- Headache
- Diarrhea
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Flexjak 11mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Flexjak 11mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Flexjak 11mg Tablet ER works:
Extended-release Flexjak 11mg tablets are Janus kinase inhibitors that suppress Janus kinase enzyme activity. This reduces immune system response and inflammation characteristic of rheumatic conditions and ulcerative colitis.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concurrent use of Flexjak 11mg Tablet ER and alcohol.
PregnancyCONSULT YOUR DOCTOR
Extended-release Flexjak 11mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Flexjak 11mg tablets are likely unsuitable for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Flexjak 11mg Extended-Release Tablets.
KidneyCAUTION
Extended-release Flexjak 11mg tablets require careful administration in individuals with advanced kidney impairment. Dosage modification of Flexjak 11mg extended-release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
The extended-release Flexjak 11mg tablet requires careful administration for individuals with significant hepatic impairment. Dosage modification of Flexjak 11mg Tablet ER might be necessary. Physician consultation is advised.
What if you forget to take Flexjak 11mg Tablet ER :
Should you forget a Flexjak 11mg Extended-Release Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Flexjak 11mg Tablet ER
| Label | Value |
|---|---|
| Type of Compound | Pyrrolopyrimidine-based compound |
| Addictive | None. |
| Treatment Category | Medication for pain relief |
| Mechanism of Action | JAK inhibitors |
